Title	Publication Date	Language	Citations
Sigma-1R Agonist Improves Motor Function and Motoneuron Survival in ALS Mice	2012/10/01	English	118
Imaging for the Diagnosis and Management of Traumatic Brain Injury	2011/01/01	English	116
Pompe Disease: From Basic Science to Therapy	2018/10/01	English	116
Treatment of Huntington's Disease	2014/01/01	English	114
Discovery of Antiepileptic Drugs	2007/01/01	English	114
Will Working Memory Training Generalize to Improve Off-Task Behavior in Children with Attention-Deficit/Hyperactivity Disorder?	2012/07/01	English	112
Neuroprotection of Fasting Mimicking Diet on MPTP-Induced Parkinson's Disease Mice via Gut Microbiota and Metabolites	2019/07/01	English	111
Microbiota Signaling Pathways that Influence Neurologic Disease	2018/01/01	English	110
Activation of the miR-34a-Mediated SIRT1/mTOR Signaling Pathway by Urolithin A Attenuates d-Galactose-Induced Brain Aging in Mice	2019/10/01	English	110
Operative Techniques for Gliomas and the Value of Extent of Resection	2009/07/01	English	110
Neural Substrates of Depression and Resilience	2017/07/01	English	110
Pediatric Brain Tumors: Current Treatment Strategies and Future Therapeutic Approaches	2009/07/01	English	109
Vagal Nerve Stimulation for Treatment-Resistant Depression	2017/07/01	English	109
Treatment of Parkinson’s Disease with Trophic Factors	2008/04/01	English	109
Multifunctional Drugs for Head Injury	2009/01/01	English	109
Episodic Ataxia Type 2	2007/04/01	English	109
IMPACT Recommendations for Improving the Design and Analysis of Clinical Trials in Moderate to Severe Traumatic Brain Injury	2010/01/01	English	109
LncRNA PVT1 Facilitates Tumorigenesis and Progression of Glioma via Regulation of MiR-128-3p/GREM1 Axis and BMP Signaling Pathway	2018/10/01	English	109
Optical Coherence Tomography (OCT): Imaging the Visual Pathway as a Model for Neurodegeneration	2011/01/01	English	108
Novel Treatment Targets for Cerebral Edema	2012/01/01	English	108
Deep Brain Stimulation for the Treatment of Epilepsy: Circuits, Targets, and Trials	2014/07/01	English	108
Lecanemab, Aducanumab, and Gantenerumab — Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease	2023/01/01	English	107
Fragile X: Leading the Way for Targeted Treatments in Autism	2010/07/01	English	107
Genetics of Alzheimer's Disease	2014/10/01	English	106
New Therapeutic Targets in the Neurovascular Pathway in Alzheimer's Disease	2008/07/01	English	106
Valproic Acid: Second Generation	2007/01/01	English	105
Migraine Treatment: Current Acute Medications and Their Potential Mechanisms of Action	2018/04/01	English	105
Investigational Therapies for Ischemic Stroke: Neuroprotection and Neurorecovery	2011/07/01	English	105
The Evidence for Hypothermia as a Neuroprotectant in Traumatic Brain Injury	2010/01/01	English	104
Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage	2015/10/01	English	104